Citation: | WANG Fei, JIN Peng-fei, MENG Fan-yue, WEI Ming-wei, LI Jing-xin, ZHU Feng-cai. Economic burden and health-related quality of life of herpes zoster disease in rural areas of Jiangsu Province[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2022, 26(6): 736-739. doi: 10.16462/j.cnki.zhjbkz.2022.06.021 |
[1] |
Dooling KL, Guo A, Patel M, et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines[J]. MMWR Morb Mortal Wkly Rep, 2018, 67(3): 103-108. DOI: 10.15585/mmwr.mm6703a5.
|
[2] |
Gershon AA, Gershon MD, Breuer J, et al. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster[J]. J Clin Virol, 2010, 48: s2-s7. DOI: 10.1016/s1386-6532(10)70002-0.
|
[3] |
Johnson RW, Bouhassira D, Kassianos G, et al. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life[J]. BMC Med, 2010, 8(1): 37. DOI: 10.1186/1741-7015-8-37.
|
[4] |
Schmader KE, Sloane R, Pieper C, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults[J]. Clin J Pain, 2007, 23(6): 490-496. DOI: 10.1097/ajp.0b013e318065b6c9.
|
[5] |
Luo N, Liu G, Li M, et al. Estimating an EQ-5D-5L value set for China[J]. Value Health, 2017, 20(4): 662-669. DOI: 10.1016/j.jval.2016.11.016.
|
[6] |
邢亚彬, 马爱霞. EQ-5D-5L中文版应用介绍[J]. 现代商贸工业, 2013, 25(1): 177-179. DOI: 10.19311/j.cnki.1672-3198.2013.01.099.
Xing YB, Ma AX. EQ-5D-5L Chinese version application introduction[J]. Modern Business Trade Industry, 2013, 25(1): 177-179. DOI: 10.19311/j.cnki.1672-3198.2013.01.099.
|
[7] |
邓慧杰, 刘芳勋. 我国带状疱疹流行病学特征及疫苗免疫规划研究进展[J]. 中国继续医学教育, 2021, 13(19): 135-138. DOI: 10.3969/j.issn.1674-9308.2021.19.039.
Deng HJ, Liu FX. Research progress of herpes zoster epidemiology and vaccine immunization program in China[J]. Chin Cont Med Edu, 2021, 13(19): 135-138. DOI: 10.3969/j.issn.1674-9308.2021.19.039.
|
[8] |
Mizukami A, Sato K, Adachi K, et al. Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Japanese adults aged 60 years or older: results from a prospective, observational cohort study[J]. Clin Drug Investig, 2018, 38(1): 29-37. DOI: 10.1007/s40261-017-0581-5.
|
[9] |
Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective[J]. BMJ Open, 2014, 4(6): e4833. DOI: 10.1136/bmjopen-2014-004833.
|